Extended-release formulations of tramadol in the treatment of chronic pain. - Wikidata - awgldk - TriplyDB

Extended-release formulations of tramadol in the treatment of chronic pain.

Extended-release formulations of tramadol in the treatment of chronic pain.

http://www.wikidata.org/entity/Q37879141

about

Review of extended-release formulations of Tramadol for the management of chronic non-cancer pain: focus on marketed formulations Tramadol Extended-Release for the Management of Pain due to Osteoarthritis Tramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review.Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely.Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain.Assessment of extended-release opioid analgesics for the treatment of chronic pain.Pain in spinal cord injury.Comments and Suggestions from Pain Specialists Regarding the CDC's Proposed Opioid Guidelines.Safety, Tolerability, and Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Multiple-Ascending-Dose Study.

P2860

Q27000905-F001883F-8D9C-4E0D-B99A-F8412247368B Q27015822-E593D0BE-1A24-4EAC-83CB-C230B4088001 Q33697613-343F66A3-B95A-42AD-A7FC-F4ABF276DB1E Q34473114-DB1D140E-10B2-4EF3-9A11-990F94103DF4 Q36821199-167484A6-DE63-4B01-9AE0-C5982B54534D Q38092855-7D834419-40B6-4812-83CD-689C43BA97FB Q38198088-9340375E-18FD-44FA-AF82-CCD91E57FDE4 Q43576588-B787E50F-0C05-4E2A-93B4-499D1B214629 Q50205856-ABF7CE82-7E05-41D2-BDC3-3B59446B574D

P2860

Extended-release formulations of tramadol in the treatment of chronic pain.

http://www.wikidata.org/entity/Q37879141

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Extended-release formulations of tramadol in the treatment of chronic pain.

@en

Extended-release formulations of tramadol in the treatment of chronic pain.

@nl

type

label

Extended-release formulations of tramadol in the treatment of chronic pain.

@en

Extended-release formulations of tramadol in the treatment of chronic pain.

@nl

prefLabel

Extended-release formulations of tramadol in the treatment of chronic pain.

@en

Extended-release formulations of tramadol in the treatment of chronic pain.

@nl

P1433

Q37879141-2A9D0C07-993D-4334-AD8C-6EDCD0489238

P1476

Q37879141-3112E995-4BD4-4B23-BF89-F93D8E7ABCD6

P2093

Q37879141-343DCE2D-8D6A-417D-B85A-1FC2C43187A3

Q37879141-3A54674F-8B0C-4EF9-8346-B606045C0C1E

P2860

Q37879141-063C36A8-8030-4842-8911-33E920EB6D7D

Q37879141-093FA3BB-743B-42D6-B826-330897CAF591

Q37879141-178003C9-7540-4FC6-A92F-CA8FF0A6BC49

Q37879141-17A7B0D0-75E5-40F4-BBCE-83AAB033D618

Q37879141-1B36DE01-4F26-4C5F-90B4-03F22278B040

Q37879141-2245C5E5-39DF-4262-841C-69399CD2E46F

Q37879141-238FDFF1-51FC-46D7-B6F9-424CC1BBCCB0

Q37879141-23C58502-855D-47B8-975C-253C97CDB2CE

Q37879141-350E4C8F-3D06-4099-96FF-62DA416CAF15

Q37879141-405AFCDB-F1D5-4F95-8463-2DEF5C02CDA2

P304

Q37879141-27CF7607-4573-446E-AA53-6FCF6EE14D30

P31

Q37879141-3DE68CD6-D5B0-4272-BF08-1F67E98056D0

P356

Q37879141-13A01533-606F-477A-8A15-7C4DC29E8B8C

P407

Q37879141-89FBB5A8-FC67-4FA0-A0DC-CB4632552C20

P433

Q37879141-0AD8AB2F-E425-4EAF-BE79-2EF8DD9537CF

P478

Q37879141-5ACA3306-F0D8-401C-9A2B-D8658B625438

P50

Q37879141-BF6A6600-F787-492C-9B29-4F7701B41D6A

P577

Q37879141-80EA88DD-D50F-40A0-AA84-59FC5B9B6F8F

P698

Q37879141-692FDFD1-18B9-4414-8638-42FDF9E42858

P921

Q37879141-4F8BC342-8C98-460F-BEF0-376F5ACF256E

P356

14656566.2011.576250

P1433

Expert Opinion on Pharmacotherapy

P1476

Extended-release formulations of tramadol in the treatment of chronic pain.

@en

P2093

Joseph V Pergolizzi

http://www.w3.org/2001/XMLSchema#string

Robert B Raffa

http://www.w3.org/2001/XMLSchema#string

P2860

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro

Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society

Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia

A systematic review of the associations between dose regimens and medication compliance.

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Tramadol as an analgesic for mild to moderate cancer pain.

Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways.

Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.

P304

1757-1768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2011.576250

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21609187

http://www.w3.org/2001/XMLSchema#string

P921